Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
Hall VG, Nguyen THO, Allen LF, Rowntree LC, Kedzierski L, Chua BY, Lim C, Saunders NR, Klimevski E, Tennakoon GS, Seymour JF, Wadhwa V, Cain N, Vo KL, Nicholson S, Karapanagiotidis T, Williamson DA, Thursky KA, Spelman T, Yong MK, Slavin MA, Kedzierska K, Teh BW.
Hall VG, et al. Among authors: wadhwa v.
Open Forum Infect Dis. 2023 Nov 2;10(11):ofad550. doi: 10.1093/ofid/ofad550. eCollection 2023 Nov.
Open Forum Infect Dis. 2023.
PMID: 38023562
Free PMC article.